Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality

COVID-19 medicines, such as molnupiravir are beginning to emerge for public health and clinical practice. On the other hand, drugs display marked variability in their efficacy and safety. Hence, COVID-19 medicines, as with all drugs, will be subject to the age-old maxim “one size prescription does n...

Descripción completa

Detalles Bibliográficos
Autores principales: AL-Taie, Anmar, Büyük, Ayşe Şeyma, Sardas, Semra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576910/
https://www.ncbi.nlm.nih.gov/pubmed/36265833
http://dx.doi.org/10.1016/j.pupt.2022.102172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576910/
https://www.ncbi.nlm.nih.gov/pubmed/36265833
http://dx.doi.org/10.1016/j.pupt.2022.102172

Ejemplares similares